On 12/20/24, Novo Nordisk A/S (NYSE: NVO) stock suffered a major decline of -17.8%, closing at $85.00. Moreover, exceptionally high trading volume at 842% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -21.7% during the last week.
Current PriceTarget Research Rating
Novo Nordisk A/S has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Novo Nordisk A/S has a good Appreciation Score of 72 but a poor Power Rating of 25, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment